Fusion Protein Biosimilars Market to Reach USD 67.1 Billion by 2036, Driven by Patent Expirations and Rising Autoimmune Disease Demand

The global Fusion Protein Biosimilars Market is projected to grow from USD 44.5 billion in 2026 to USD 67.1 billion by 2036, registering a CAGR of 4.2% during the forecast period. Market growth is being driven by large-scale patent expirations